Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA,
Target Price
The average target price of NEPH is 7.1 and suggests 73% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increas
Buy
Sell